Literature DB >> 9430686

High fidelity of internal strand transfer catalyzed by human immunodeficiency virus reverse transcriptase.

J DeStefano1, J Ghosh, B Prasad, A Raja.   

Abstract

A system to study the fidelity of internal strand transfer events was constructed. A donor RNA, on which reverse transcriptase (RT)-directed DNA synthesis was initiated, shared homology with an acceptor RNA, to which DNAs initiated on the donor could transfer. The homology occurred over a 119-base internal region of the donor which coded for the N-terminal portion of the alpha-lac gene. Polymerase chain reaction (PCR) was used to amplify DNA synthesis products. The PCR products were then digested with PvuII and EcoRI and ligated into a vector which had this same region excised. Transformed Escherichia coli were screened for the ability to produce a functional beta-galactosidase protein by blue-white phenotype analysis with white colonies scored as those with errors in alpha-lac. Products synthesized on the donor were used to assess the error rate of human immunodeficiency virus-RT while products transferring to and subsequently extended on the acceptor (transfer products) were used to monitor transfer fidelity. Human immunodeficiency virus-RT made approximately 1 error per 7500 bases copied in the assay. Nucleocapsid protein (NCp), although stimulating strand transfer 3-fold, had no effect on RT fidelity. Transfer products in the absence of NCp had essentially the same amount of errors as donor-directed products while those produced with NCp showed a slight increase in error frequency. Overall, strand transfer events on this template were highly accurate. Since experiments with other templates have suggested that transfer is error prone, the fidelity of strand transfer may be highly sequence dependent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430686     DOI: 10.1074/jbc.273.3.1483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching.

Authors:  K A Delviks; V K Pathak
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Fifteen to twenty percent of HIV substitution mutations are associated with recombination.

Authors:  Timothy E Schlub; Andrew J Grimm; Redmond P Smyth; Deborah Cromer; Abha Chopra; Simon Mallal; Vanessa Venturi; Caryll Waugh; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

3.  RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription.

Authors:  C M Smith; J S Smith; M J Roth
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Effect of reaction conditions and 3AB on the mutation rate of poliovirus RNA-dependent RNA polymerase in a alpha-complementation assay.

Authors:  Jeffrey J DeStefano
Journal:  Virus Res       Date:  2009-10-20       Impact factor: 3.303

5.  Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.

Authors:  Siarhei Kharytonchyk; Steven R King; Clement B Ndongmo; Krista L Stilger; Wenfeng An; Alice Telesnitsky
Journal:  J Mol Biol       Date:  2016-04-10       Impact factor: 5.469

6.  Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.

Authors:  Vasudevan Achuthan; Brian J Keith; Bernard A Connolly; Jeffrey J DeStefano
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

7.  Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  BMC Biochem       Date:  2015-05-03       Impact factor: 4.059

8.  Primer Extension Reactions for the PCR- based α- complementation Assay.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  Bio Protoc       Date:  2015-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.